These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23360847)

  • 1. Inhibition of renin-angiotensin system: implications for diabetes control and prevention.
    Prabhakar SS
    J Investig Med; 2013 Mar; 61(3):551-7. PubMed ID: 23360847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control.
    Perkins JM; Davis SN
    Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):147-52. PubMed ID: 18316950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diabetes mellitus].
    Ura N; Takizawa H; Sasaki H
    Nihon Rinsho; 2012 Sep; 70(9):1593-8. PubMed ID: 23012809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking the renin-angiotensin-aldosterone system to prevent diabetes mellitus.
    McGuire DK; Winterfield JR; Rytlewski JA; Ferrannini E
    Diab Vasc Dis Res; 2008 Mar; 5(1):59-66. PubMed ID: 18398815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
    Leiter LA; Lewanczuk RZ
    Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
    Boucek P
    Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension and diabetes: role of the renin-angiotensin system.
    Jandeleit-Dahm K; Cooper ME
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):469-90, vii. PubMed ID: 16959581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure.
    Mori J; Zhang L; Oudit GY; Lopaschuk GD
    J Mol Cell Cardiol; 2013 Oct; 63():98-106. PubMed ID: 23886814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-angiotensin-system blockade in the prevention of diabetes.
    Ostergren J
    Diabetes Res Clin Pract; 2007 May; 76 Suppl 1():S13-21. PubMed ID: 17320999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [RAAS and insulin resistance].
    Motoshima H; Araki E
    Nihon Rinsho; 2012 Sep; 70(9):1542-9. PubMed ID: 23012801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property.
    Yamagishi S; Takeuchi M
    Med Hypotheses; 2005; 64(3):476-8. PubMed ID: 15617852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of renin-angiotensin system in diabetes mellitus with hypertension].
    Itoh H
    Nihon Rinsho; 2003 Jul; 61(7):1145-53. PubMed ID: 12877076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle.
    Henriksen EJ; Prasannarong M
    Mol Cell Endocrinol; 2013 Sep; 378(1-2):15-22. PubMed ID: 22564510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin receptor blockers improve insulin signaling and prevent microvascular rarefaction in the skeletal muscle of spontaneously hypertensive rats.
    Rizzoni D; Pasini E; Flati V; Rodella LF; Paiardi S; Assanelli D; De Ciuceis C; Porteri E; Boari GE; Rezzani R; Speca S; Favero G; Martinotti S; Toniato E; Platto C; Agabiti-Rosei E
    J Hypertens; 2008 Aug; 26(8):1595-601. PubMed ID: 18622238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory networks and complex interactions between the insulin and angiotensin II signalling systems: models and implications for hypertension and diabetes.
    Cizmeci D; Arkun Y
    PLoS One; 2013; 8(12):e83640. PubMed ID: 24400038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of type II diabetes by inhibiting the renin-angiotensin system].
    Scheen AJ
    Rev Med Liege; 2002 Jul; 57(7):449-52. PubMed ID: 12233220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of protective effects induced by blockade of the renin-angiotensin system: novel role of the pancreatic islet angiotensin-generating system in Type 2 diabetes.
    Leung PS
    Diabet Med; 2007 Feb; 24(2):110-6. PubMed ID: 17257271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for renoprotection by blockade of the renin-angiotensin-aldosterone system in hypertension and diabetes.
    Karalliedde J; Viberti G
    J Hum Hypertens; 2006 Apr; 20(4):239-53. PubMed ID: 16452996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of renin blockers in the prevention of diabetes.
    Alkhenizan AH; Alswes MA
    Saudi Med J; 2007 Jan; 28(1):91-5. PubMed ID: 17206297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of angiotensin in obesity and metabolic disease.
    Mathai ML; Chen N; Cornall L; Weisinger RS
    Endocr Metab Immune Disord Drug Targets; 2011 Sep; 11(3):198-205. PubMed ID: 21831033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.